Further, subjects in the highest quartile of p-tau had an increased HR of death in severe dementia compared with participants in the three lowest quartiles (adjusted HR 1.88, 95 % CI 1.03–3.45); otherwise, p-tau was not significantly related to these outcomes (Additional file 1: Table S1). The gene discussed is MAPT; the disease is dementia.